CLINICAL_TRIALS
trial_result
· 2018-11-01
Clinical Trial Update: PF-06291874 Multiple Ascending Dose Study In Type 2 Diabetes Mellitus Patients [Phase 1]
Summary
Phase 1 multiple ascending dose study of PF-06291874 in adults with type 2 diabetes completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2018-11-01